No Data
No Data
No Data
No Data
No Data
TenX Keane Acquisition Announces Contribution to Trust Account in Connection With Extension Amendment Proposal
New York, NY, Jan. 10, 2024 (GLOBE NEWSWIRE) -- TenX Keane Acquisition (NASDAQ:TENKU, TENK, TENKR)) (the "Company"), announced today that if the proposal to amend the Company's Amended and Restated Memorandum and
GlobeNewswireJan 11 03:29
Citius Unit to Merge With TenX Keane to Form Public Company
Seeking AlphaOct 24, 2023 21:23
Citius' Oncology Unit to Go Public Via SPAC Merger
By Dean Seal Citius Pharmaceuticals has signed a deal to merge its oncology-focused subsidiary with the blank-check company TenX Keane Acquisition and have the business become its own public company.
Dow JonesOct 24, 2023 19:46
TenX Keane Acquisition Halted, News Pending
InvestingOct 24, 2023 19:34
Citius Pharmaceuticals to Receive $675 M in Equity of Citius Oncology
Citius Pharmaceuticals to Receive $675 M in Equity of Citius Oncology
Dow JonesOct 24, 2023 19:33
Citius Pharmaceuticals to Retain About 90% Majority Control in Publicly Listed Citius Oncology, Inc. Post Transaction
Citius Pharmaceuticals to Retain About 90% Majority Control in Publicly Listed Citius Oncology, Inc. Post Transaction
Dow JonesOct 24, 2023 19:33
No Data
No Data